Effectiveness of Homoharringtonine (Omacetaxine Mepesuccinate) for Treatment of Acute Myeloid Leukemia: A Meta-Analysis of Chinese Studies
- 1 January 2015
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 15 (1) , 13-21
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Omacetaxine mepesuccinate for the treatment of leukemiaExpert Opinion on Pharmacotherapy, 2011
- High-dose homoharringtonine versus standard-dose daunorubicin is effective and safe as induction and post-induction chemotherapy for elderly patients with acute myeloid leukemia: a multicenter experience from ChinaMedical Oncology, 2011
- Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemiaJournal of Cancer Research and Clinical Oncology, 2010
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetBlood, 2010
- A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from ChinaJournal of Hematology & Oncology, 2009
- Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotypeLeukemia & Lymphoma, 2008
- Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemiaLeukemia, 2006
- Acute Myeloid LeukemiaHematology-American Society Hematology Education Program, 2004
- HomoharringtonineCancer, 2001
- Structures of harringtonine, isoharringtonine, and homoharringtonineTetrahedron Letters, 1970